Cargando…
Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic, immune-mediated, non-curable disease. The incidence of IBD appears to have risen over the last few decades especially in the pediatric age group. IBD usually presents with gastrointestinal symptoms, including abdominal pain, diarrhea, and bleeding per r...
Autores principales: | El-Matary, Wael, Bernstein, Charles N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396532/ https://www.ncbi.nlm.nih.gov/pubmed/32903330 http://dx.doi.org/10.3389/fped.2020.00400 |
Ejemplares similares
-
Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017) -
Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020) -
Advances in Nutritional Management of Pediatric Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2021) -
The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016) -
Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)